The FDA approval to expand Exelixis' Cabometyx into neuroendocrine tumors is witnessing encouraging uptake and boosting ...

Risk prediction models incorporating novel biomarkers show comparable discrimination to established risk factors.

Hypoxia-inducible factors (HIFs), ETS-1, MYC, and β-catenin act as master regulators that constitutively activate oncogenic ...

Iovance shares slid 6% after unveiling a $350 million stock offering, raising dilution concerns while funding growth plans for Amtagvi and its pipeline.

Obesity is now a leading preventable cause of cancer after smoking, triggering biological changes like inflammation and ...

Presentations Highlight the Versatility of Clearside’s SCS Microinjector® Platform for the Treatment of Multiple Retinal Diseases -- CLS-AX ...

Although hematologic, dermatologic, and rheumatologic features are the most common to present in patients with VEXAS, ...

Humberto Duran, who was wrongfully incarcerated for nearly three decades, has filed a lawsuit against the Los Angeles County ...

WPBF 25 goes "On the Record" on how local medical facilities are combating cancer.

A few of the area's most revered physicians reflect on the moments that define their careers, the breakthroughs shaping ...

Separately Secures Access to OneGI Through Brentwood Pharmacy AgreementGimoti Specialty Pharmacy Network to Almost Double with Additional ...